Publications & White Papers

  • 2027 Medicare Physician Fee Schedule (PFS) Proposed Rule

    The Impact on Drug Manufacturers and ASP

    July 2026

  • Once the Dust Settles on Q2 ASP Reporting

    Documentation Updates Related to the New CMS ASP Reporting Requirements

    July 2026

  • The Current Landscape of Service-Fee FMV

    A Regulatory, Compliance, and Financial Perspective of CMS’s Bona Fide Service Fee (BFSF) Framework

    June 2026

  • GP Compliance For Manufacturers in the Third Party Provider (TPP) Managed Services Environment

    Helping to tell your GP Compliance Story

    May 2026

  • Maximum Fair Price (MFP) Effectuation for Part B Drugs

    A Manufacturer-Focused Compliance Perspective and HELIO’s MFP Effectuation & Part B Drug Compliance Support

    May 2026

  • Government Programs Participation for Emerging Pharma and Biotech

    A Case Study in Understanding Opportunities and Managing Risks: Will You be Ready on Day 1?

    April 2026

  • Applying Smart Technology to Class of Trade and 340B Validation

    A Discussion of Recent HELIO Audits of COT Assignments and 340B Validations, and the Various Types of Issues Identified.

    April 2026

  • Government Programs Compliance "Health Check"

    Evaluating your GP Audit Readiness Through Compliance Assessments to Identify Potential Gaps and Improve Documentation.

    Mar 2026

  • Navigating CAA 2026 PBM Reforms: Critical Concerns for Drug Manufacturers

    An Overview of the 2026 Consolidated Appropriations Act and what the PBM Reforms mean for Pharmaceutical Manufacturers

    Mar 2026

  • Update on the CMS ASP Final Rule which goes into Effect Q1 2026

    CMS Publishes a Holiday Gift with the Promised FAQ

    Jan 2026

  • CMS’s Proposed GLOBE and GUARD Models

    A Side-By-Side Summary of What Pharmaceutical Manufacturers Need to Know

    Dec 2025

  • Our Thoughts on Priorities for the New ASP Requirements, Effective Q1 2026

    Preparing to Defend your Reasonable Assumptions

    Nov 2025

  • Summary of the GENEROUS Model Request for Applications (RFA)

    A Detailed Look into The CMS Request for Applications from Applicable Manufacturers

    Nov 2025

  • Most Favored Nation (MFN) pricing through Status Supplemental Rebates

    Recent ways CMS is looking to effectuate MFN pricing through Status Supplemental Rebates

    Nov 2025

  • Shifting Compliance From Detection to Direction

    How AI Is Rewriting the Rules of Data-Driven Compliance

    Oct 2025

  • Government Programs for the Compliance Officer

    A HELIO Case Study: GP from the View of a Compliance Officer

    Oct 2024

  • Mergers & Acquisitions Government Price Reporting, Due Diligence and Avoiding Transition Nightmares

    Common Recurring Issues in Life Sciences M&A and How to Address them.

    April 2024

  • The Guardians of Innovation

    Compliance Executives in the Age of the AI-Driven Pharma Enterprise

    Mar 2024

  • Helio’s Seventh Annual Patient Services Compliance Survey

    Surprising Developments in 2023

    Mar 2024

  • AI in Life Science Enterprise

    Real World Ethical, Compliance, and Security Considerations of AI in the Life Science Industry

    Feb 2024

  • The Ongoing Saga of Patient Definition, or Lack Thereof, in the 340B Program

    Patient definition in the 340b program becomes more complicated after recent court decision.

    Jan 2024

  • Back to Basics: Compliance Oversight of Government Pricing Programs

    Where We Are Now and Where We Are Headed

    Dec 2023

  • Embracing Generative Artificial Intelligence

    The Race to Reshape the Life Sciences Industry

    May 2023

  • 6th Annual Patient Services Compliance Survey

    The Journey Continued in 2022

    Jan 2023

  • 5th Annual Patient Services Compliance Survey

    Patient Support Program Compliance Continues Evolving

    DEC 2021

  • Looking for Compliance Risks in Oceans of Data

    Leveraging machine learning & advanced anomaly detection to address the flood of digital communications data

    SEP 2021

  • Your Data & You: Who Works for Whom?

    The Burning Platform for Compliance Data Analytics

    MAY 2021

  • Operating in the Gray Zone

    Patient Support Programs & the Guardrails to Mitigate Risk

    MAY 2021

  • 4th Annual Patient Services Complaince Survey

    Patient Services Program Compliance Continues Evolving

    DEC 2020

  • Monitoring the New Normal

    Top 5 Compliance Challenges to Consider in the Changing Digital Workspace

    JUL 2020

  • Patient Services Compliance Survey

    Trends & Insights into this Highly Scrutinized Area

    FEB 2019

  • HELIO Patient Services Compliance Survey

    The Latest Trends & Lessons Learned

    NOV 2019